ArticleCurrent cancer drug targets2025

Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway.

Zhuanxia Dong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.